Digital Pathology Platform Enterprise Software Licenses
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 75N95024R00118
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 513210 Software Publishers
- Place of performance
- Rockville, Maryland 20850, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse is issuing a Sources Sought Notice to procure enterprise-level digital pathology software tools that are equivalent to the HALO product line from Indica Labs. The government is seeking information from qualified sources, including small businesses, that can provide a commercial solution meeting the specific product requirements. Respondents must submit their DUNS number, business size and type, and a capability statement by September 3, 2024. The government will use the responses to determine the appropriate acquisition method, including whether a set-aside is possible, but responses will not be considered proposals.
This is not a set-aside procurement. The anticipated period of performance is a 10-month base period with two one-year options. While there is no incumbent information provided, the government is particularly interested in the HALO software, which is used extensively by the National Cancer Institute, NCATS, and the National COVID Cohort Collaborative. No award value or budget range is specified, as this is a sources sought notice rather than a solicitation.
Notice text
SAM.gov Contract Opportunities
SOURCES SOUGHT NOTICE
- Sources Sought Number: 75N95024R00118
- Title: Digital Pathology Platform Enterprise Software Licenses
- Classification Code: 7A21
- NAICS Code: 513210 Software Publishers
- Description:
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.
This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only.
The Government is especially interested in determining (1) the availability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.
Background:
HALO digital pathology software provides a platform for specialized analysis and management of digital histology images. HALO is a product of Indica Labs. The platform is hosted by NCATS and made available to multiple users of the NCATS Secure Scientific Platforms Environment (the “Environment”), an NCATS-hosted platform for collaboration across NIH institutes and centers, other Government agencies, and external collaborators. HALO receives particularly intensive use by users from the National Cancer Institute (NCI), NCATS, and the National COVID Cohort Collaborative (N3C).
Project requirements:
This requirement is, on a brand-name-or-equal basis, to renew enterprise licenses for the installed base of HALO digital pathology software tools (i.e. “brand-name”), or to obtain enterprise-level digital pathology software tools that constitute a platform fully equal in form, fit, and function to the following HALO products (i.e. “or equal”):
Contract line item description
See Attaachment
Anticipated period of performance: The anticipated period of performance is one ten (10) month base, with two one-year options.
Capability statement /information sought. Respondents must be registered in the System for Award Management (SAM), and address the following questions:
- Provide your DUNS number, organization name, address, and point of contact. If your business is a small business, include your size and type of business (e.g., 8(a), HubZone, etc., SDVOSB, etc.) pursuant to the applicable NAICS code
- Provide a capability statement that addresses the project requirements listed above, with particular attention to the description of your commercial solution and general estimates regarding the length of time required to implement the solution.
- Provide any other information that may be helpful in developing or finalizing the acquisition requirements.
The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required.
The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone numbers, and e-mail addresses.
All responses to this notice must be submitted by email to Nick Niefeld, Contract Specialist, at nick.niefeld@nih.gov, and reference sources sought notice number 75N95024R00118.
The response must be received on or before Wednesday, September 3, 2024 at 9:00 a.m. Eastern time.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a synopsis and solicitation may be published in SAM.gov Contract Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
Files
| File | Type | Posted |
|---|---|---|
| Sources Sought Notice.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Renewal of Digital Pathology Platform Enterprise Software Licenses | Solicitation | |
| Notice of Intent - Digital Pathology Platform Enterprise Software Licenses | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories | National Institute on Drug Abuse | Total Small Business | |
| Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories | National Institute on Drug Abuse | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity